IRWD
Ironwood Pharmaceuticals Inc
3.80$
+3.3%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 28.5% | 30.5% | 60.1% | 35.5% | 10.8% | 16.8% | 48.5% | -17.7% | 39.0% | 156.3% | 4.8% | 51.6% | 47.7% | |
| 0.4% | 0.4% | 0.7% | 0.5% | 0.6% | 0.5% | 1.2% | 0.5% | 0.4% | 2.9% | 0.4% | 0.4% | 0.7% | |
| 7.0% | 7.4% | 11.2% | 9.1% | 9.1% | 5.0% | 12.9% | 5.3% | 3.0% | 25.1% | 3.4% | 2.9% | 5.8% | |
| -4.2% | -7.3% | 44.8% | 12.1% | -11.6% | -37.1% | 121.7% | -68.8% | -20.7% | 154.0% | -56.2% | -11.3% | -6.2% | |
| 0.0% | 0.2% | 0.1% | 0.1% | 0.0% | 0.0% | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| -19.9% | -3.6% | -0.1% | -0.1% | 0.0% | 0.0% | -0.1% | 0.0% | 0.0% | 0.0% | – | – | – | |
| 0.0% | 0.0% | -0.8% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -27.3% | -16.6% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | |
| -65.9% | -43.3% | -20.8% | -52.3% | -29.6% | -16.4% | 0.0% | 0.1% | 0.0% | 0.3% | 0.0% | -176.7% | -51.3% | |
| -57.3% | -16.4% | 39.2% | -17.0% | -18.9% | 0.4% | 48.4% | -18.3% | 39.0% | 157.3% | 4.7% | -125.0% | -3.5% | |
| 28.5% | 30.3% | 60.0% | 35.4% | 10.8% | 16.8% | 48.4% | -17.7% | 39.0% | 156.3% | 4.8% | 51.6% | 47.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.